个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
王桂玲, 女,现为中国医科大学生命科学学院,省部共建医学细胞生物学重点实验室,分子细胞生物学教研室教授,博士生导师,博士后导师,三级教授,沈阳市拔尖人才。主持承担三项国家自然科学基金项目及三项辽宁省科研项目课题等。曾获得辽宁省科学技术二等奖及辽宁省自然科学学术成果奖二等奖。从2019年至今,以通讯作者身份在Cell Death & Differentiation、Cell Death & Desease、Materials Today Bio及Chinese Chemical Letters等国际期刊发表中科院1区9篇,2区2篇论文。现培养硕士及博士生 10 余名,其中培养的研究生曾获得辽宁省硕士优秀毕业学术论文,辽宁省优秀毕业生,国家奖学金及沈阳市优秀研究生等称号。为Theranostics、Spandidos Publications等多个SCI杂志的审稿人。研究方向为肿瘤相关功能基因信号调控网络、肿瘤细胞代谢异常及LncRNA与肿瘤等。
上传附件
支持扩展名:.rar .zip .doc .docx .pdf .jpg .png .jpeg上传附件
支持扩展名:.rar .zip .doc .docx .pdf .jpg .png .jpeg上传附件
支持扩展名:.rar .zip .doc .docx .pdf .jpg .png .jpeg主持承担三项国家自然科学基金项目及三项辽宁省科研项目课题等。
近五年发表的代表性论文 :
1.Zhang S, Guo A, Wang H, Liu J, Dong C, Ren J, Wang G*. Oncogenic MORC2 in CancerDevelopment and Beyond,GenesDis. 2023,11(2):861-873. (IF=6.8,中科院1区).
2.Wang TZ, Ren JY, ZhangDX, Wang H, Du JJ , Jiang XD, Wang GL⁎ .Development of functional dye with redshifted absorption based on Knoevenagelcondensation at 1-site in phenyl[b]-fused BODIPY.Chinese Chemical Letters.2023.7(IF=9.1,中科院1区).
3.Chen YC, Wang z, Zhang DX, Gong XY, Du JJ, JiangXD, Wang GL*. Constructionof diene-extended meso-CF3-BODIPY for spectroscopic study and photothermalexploration,Dyes and Pigments, 2023,6 (IF=4.5中科院1区).
4.YeCJ , Zhang S, Zhang DX , Shen Y , Wang Z , WangH , Ren JY , Jiang XD*, Du JJ*, Shang R, WangGL∗.Engineering J-aggregates for NIR-induced meso-CF3-BODIPY nanoparticles byactivated apoptosis mechanism in photothermal therapy. Chinese Chemical Letters,2023.2(IF=9.1中科院1区).
5. Li R, Ren J, Zhang D, Lv M, Wang Z, Wang H, Zhang S, Du J, Jiang XD, Wang G*. Attachment of -tBu groupsto aza-BODIPY core at 3,5-sites with ultra-large Stokes shift to enhancephotothermal therapy through apoptosis mechanism. Mater Today Bio. 2022 Sep29;16:100446.(IF=8.2中科院1区).
6. Zhao J, Wang H, Zhang D, Shen Y, Zhang S, Ren J, Wang Z, Sun YN, Du J, Jiang XD, WangG*. Synthesis of aza-BODIPYs withbarrier-free rotation of the -tBu group at 3-site and enhancement ofphotothermal therapy by triggering cancer cell apoptosis. J Mater Chem B. 2022 Oct26;10(41):8443-8449. (IF=7.0中科院2区).
7.Ren J, Wang B, Wu Q, Wang G*. Combination ofniclosamide and current therapies to overcome resistance for cancer: Newfrontiers for an old drug. Biomed Pharmacother. 2022 Nov;155:113789(IF=7.5,中科院1区).
8. Wang Z, Ren J, Du J, WangH, Liu J, Wang G*. Niclosamide as a Promising Therapeutic Player in HumanCancer and Other Diseases. Int J Mol Sci. 2022 Dec 17;23(24):16116. (IF=6.2,中科院2区)
9.Wang H, ZhangL, Luo Q, Liu J, Wang G*. MORC protein family-relatedsignature within human disease and cancer. Cell Death Dis. 2021 Nov 27;12(12):1112.(IF=9.685).
10.Liu J, Zhang Q, Ruan B, Chen W, Zheng J, Xu B, Jiang P, Miao Z, Li F, Guo JY,Cao L, Wang G*. MORC2 regulatesC/EBPα-mediated cell differentiation via sumoylation. Cell Death Differ. 2019Oct;26(10):1905-1917(IF=10.717).
作为第一完成人获得辽宁省自然科学学术成果奖二等奖;
以主要完成人获得辽宁省科学技术二等奖及辽宁省教学成果奖三等奖;
曾获得“辽宁省高等学校优秀青年骨干教师”荣誉称号;
辽宁省硕士优秀毕业论文指导教师。
所在平台情况:文件上传中...